Search results for: 'structural ad drug'

18 Dec 2015  |  Global  |  Megatrends

The Global Future of Work—The Future Place and Structure of Work

Trade, Technology, and Transparency to Shape the Workplace in 2025

Infographics

×

The Global Future of Work—The Future Place and Structure of Work applies a multi-faceted approach to answering the question: where will work take place in 2025? Topics include international trends, such as mega-regional trade deals and right-shoring considerations; workplace design and format trends, such as smart offices and innovative retail spac...

The aim of this study is to research, analyze, and forecast digital retailing in the automotive industry. Digital retailing is creating a revolution in the way cars are being sold or the way a brand is being experienced in prime areas of a city. The research identifies retail strategies and opportunities for future growth of automotive original equ...

02 Feb 2017  |  Europe  |  Market Research

European Next-generation Sequencing Services Market, Forecast to 2023

Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

Infographics

×

The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-changing Compa...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

This edition of Trend Opportunity Profiles features trend advancements in health, wellness, and nutrition featuring fitness as a service, nootropics, advancements in bionics, cultured meat, sustainable nourishment, obesity drugs, synthetic skin, and virtual nursing. Frost & Sullivan's Trend Opportunity Profiles series covers specific opportuniti...

23 May 2017  |  Europe  |  Market Research

Growth Opportunities in the UK Water Retail Market, Forecast to 2022

A Dynamic Market Characterised by Service and Delivery Innovation by Suppliers

Infographics

×

Customer-centric innovation, digital transformation, value-added services, and exemplary customer service will drive the UK water retail market going forward. The market revenue is estimated at £4 billion, with a non-domestic customer base of about 1.2 million. This study includes the revenue forecast for 2017–2022 for three different scenarios: bu...

18 Jan 2017  |  North America  |  Market Research

Global Precision Medicine Growth Opportunities, Forecast to 2025

Strategies and Tactics for Accelerating Growth in a Transforming Market

Infographics

×

Precision medicine aims to integrate personalized health data both from direct (quantifiable) and indirect (quantifiable) sources probing the deepest mysteries affecting individual health and well-being. Rising pressures to decrease healthcare cost globally, emergence of value-based reimbursement models, and healthcare digitization trends are trans...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...